These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 15159026)
41. Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers. Chan TF; Su TH; Yeh KT; Chang JY; Lin TH; Chen JC; Yuang SS; Chang JG Int J Oncol; 2003 Sep; 23(3):599-604. PubMed ID: 12888893 [TBL] [Abstract][Full Text] [Related]
42. Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation. Kloth JN; Gorter A; ter Haar N; Corver WE; Jordanova ES; Kenter GG; Fleuren GJ Mol Immunol; 2008 Jan; 45(1):152-9. PubMed ID: 17560652 [TBL] [Abstract][Full Text] [Related]
43. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression. Song Y; Zhang C Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605 [TBL] [Abstract][Full Text] [Related]
44. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Sova P; Feng Q; Geiss G; Wood T; Strauss R; Rudolf V; Lieber A; Kiviat N Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):114-23. PubMed ID: 16434596 [TBL] [Abstract][Full Text] [Related]
45. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Enokida H; Shiina H; Urakami S; Terashima M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Igawa M; Dahiya R Cancer; 2006 Jan; 106(1):79-86. PubMed ID: 16323173 [TBL] [Abstract][Full Text] [Related]
46. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma. Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411 [TBL] [Abstract][Full Text] [Related]
47. Aberrant methylation during cervical carcinogenesis. Virmani AK; Muller C; Rathi A; Zoechbauer-Mueller S; Mathis M; Gazdar AF Clin Cancer Res; 2001 Mar; 7(3):584-9. PubMed ID: 11297252 [TBL] [Abstract][Full Text] [Related]
48. Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma. Luczak MW; Roszak A; Pawlik P; Kędzia H; Kędzia W; Malkowska-Walczak B; Lianeri M; Jagodziński PP Int J Oncol; 2012 Mar; 40(3):860-6. PubMed ID: 21887463 [TBL] [Abstract][Full Text] [Related]
49. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women. Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851 [TBL] [Abstract][Full Text] [Related]
50. Methylation of OSMR gene is frequently observed in non-invasive colorectal cancer. Hibi K; Goto T; Sakuraba K; Shirahata A; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2011 Apr; 31(4):1293-5. PubMed ID: 21508378 [TBL] [Abstract][Full Text] [Related]
51. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer. Lando M; Fjeldbo CS; Wilting SM; C Snoek B; Aarnes EK; Forsberg MF; Kristensen GB; Steenbergen RD; Lyng H Epigenetics; 2015; 10(10):970-80. PubMed ID: 26291246 [TBL] [Abstract][Full Text] [Related]
52. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients. Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164 [TBL] [Abstract][Full Text] [Related]
53. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis. Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087 [TBL] [Abstract][Full Text] [Related]
54. Titrimetric immunohistochemical evaluation of DNA hypomethylation in uterine tumours. Wolk M; Martin JE J Clin Pathol; 2009 Nov; 62(11):1039-42. PubMed ID: 19861565 [TBL] [Abstract][Full Text] [Related]
55. Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer. Zhang X; Zheng Z; Yingji S; Kim H; Jin R; Renshu L; Lee DY; Roh MR; Yang S Oncol Rep; 2014 Jun; 31(6):2587-92. PubMed ID: 24788695 [TBL] [Abstract][Full Text] [Related]
56. DNA methylation in serum and tumors of cervical cancer patients. Widschwendter A; Müller HM; Fiegl H; Ivarsson L; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M Clin Cancer Res; 2004 Jan; 10(2):565-71. PubMed ID: 14760078 [TBL] [Abstract][Full Text] [Related]
57. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Wang SS; Smiraglia DJ; Wu YZ; Ghosh S; Rader JS; Cho KR; Bonfiglio TA; Nayar R; Plass C; Sherman ME Cancer Res; 2008 Apr; 68(7):2489-97. PubMed ID: 18381458 [TBL] [Abstract][Full Text] [Related]
58. Promoter methylation in the PTCH gene in cervical epithelial cancer and ovarian cancer tissue as studied by eight novel Pyrosequencing® assays. Löf-Öhlin ZM; Levanat S; Sabol M; Sorbe B; Nilsson TK Int J Oncol; 2011 Mar; 38(3):685-92. PubMed ID: 21206974 [TBL] [Abstract][Full Text] [Related]
59. DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. de Capoa A; Musolino A; Della Rosa S; Caiafa P; Mariani L; Del Nonno F; Vocaturo A; Donnorso RP; Niveleau A; Grappelli C Oncol Rep; 2003; 10(3):545-9. PubMed ID: 12684621 [TBL] [Abstract][Full Text] [Related]
60. Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings. Huang RL; Su PH; Liao YP; Wu TI; Hsu YT; Lin WY; Wang HC; Weng YC; Ou YC; Huang TH; Lai HC Clin Cancer Res; 2017 Jan; 23(1):263-272. PubMed ID: 27507616 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]